Related Experiment Video

Updated: May 25, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients

B Schilling1, E S Halstead, P Schuler

  • 1Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.

Cancer Immunology, Immunotherapy : CII
|January 25, 2012
PubMed
Abstract

Insights

IRX-2 enhances natural killer (NK) cell function in head and neck squamous cell cancer (HNSCC) patients more effectively than IL-2. This biologic restores NK cell cytotoxicity and receptor expression, offering potential for HNSCC therapy.

Area of Science:

  • Immunology
  • Oncology
  • Biotherapeutics

Background:

  • Head and neck squamous cell cancer (HNSCC) is associated with compromised natural killer (NK) cell function.
  • IRX-2 is a biologic agent investigated for HNSCC therapy with promising clinical outcomes.

Purpose of the Study:

  • To evaluate the efficacy of IRX-2 in restoring human NK-cell functions in vitro.
  • To compare the effects of IRX-2 with recombinant human interleukin-2 (rhIL-2) on NK cells from HNSCC patients.

Main Methods:

  • Peripheral blood mononuclear cells (PBMC) were isolated from HNSCC patients and normal controls.
  • NK-cell phenotype, cytotoxicity, and cytokine expression were analyzed using flow cytometry before and after culture with IRX-2 or rhIL-2.
  • The impact of transforming growth factor-beta (TGF-β) on NK-cell function was assessed.

Main Results:

  • HNSCC patients exhibited impaired NK-cell cytotoxicity linked to reduced expression of NKG2D, NKp30, and NKp46 receptors.
  • IRX-2 significantly up-regulated NK-cell receptor expression and cytotoxicity in HNSCC patients' NK cells, outperforming rhIL-2.
  • IRX-2 protected NK cells from TGF-β-mediated suppression and restored receptor expression and cytotoxicity, unlike rhIL-2. pSMAD expression was decreased by IRX-2.

Conclusions:

  • IRX-2 demonstrates superior efficacy compared to IL-2 in enhancing NK-cell cytotoxicity and function in HNSCC patients.
  • IRX-2 shows potential as a valuable component in future HNSCC therapeutic strategies.
  • Restoration of NK-cell function by IRX-2 may improve treatment outcomes for HNSCC.

More Related Videos

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies08:37

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

Published on: February 15, 2021

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase (G6PI)-Induced RA Mice

Published on: January 31, 2020

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...